Kappac Pharma Ltd Stock Analysis

BSE: 506938 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - Make an Informed Decision on Kappac Pharma

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity

2. Valuation

Undervalued
P/E P/S EV/EBITDA

3. Price Trend

FAQ's

1. Is Kappac Pharma Ltd. a good quality company?

Data is not available for this company.

2. Is Kappac Pharma Ltd. undervalued or overvalued?

No data found

3. Is Kappac Pharma Ltd. a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Kappac Pharma Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Kappac Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide
Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14TTM
ROCE % -12.9%-77.7%-37.3%190.3%-91%-0.2%-0.3%-0.2%-0.3%-0.3%-

Growth Parameters

Growth Parameters Colour Code Guide
Sales 3.40.8002000000
YoY Gr. Rt. %--77.5%-100%NANA-100%NANANANA-
Adj EPS -2-7.9-1.83.60-0.2-0-0-0-0-0.7
YoY Gr. Rt. %-NANANA-100%NANANANANA-
BVPS (₹) 13.15.13.7-0-012.510.110.110.112.612.6
Adj Net Profit -0.2-0.6-0.10.300-0.1-0.1-0.1-0.1-2
Cash Flow from Ops. -0.7-0.10-0.30-16.8-0.7-0.1-4.44.2-
Debt/CF from Ops. -0-0.2-0.60-1-00-4300.1-

CAGR

CAGR Colour Code Guide
9 Years 5 Years 3 Years 1 Years
Sales -100%-100%NANA
Adj EPS NANANANA
BVPS -0.407.625.3
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide
Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14TTM
Return on Equity % -13.4-79.6-38.6196.4-15.9-0.2-0.3-0.3-0.4-0.3-5.8
Op. Profit Mgn % -2.3-100.5000000000
Net Profit Mgn % -4.6-79.8000000000
Debt to Equity 0000-1.80.100.1000
Working Cap Days 6391,508004000000
Cash Conv. Cycle -302-74100-94000000

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Kappac Pharma Ltd.

Standalone Consolidated
TTM EPS (₹) -0.7 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹.) 12.6 -
Reserves (₹ Cr.) 8 -
P/BV 8.97 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 112.85 / 112.85
All Time Low / High (₹) 3.20 / 734.75
Market Cap (₹ Cr.) 341
Equity (₹ Cr.) 30.3
Face Value (₹) 10
Industry PE 39.8

Management X-Ray of Kappac Pharma :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Analyst's Notes

News

About Kappac Pharma Ltd

Kappac Pharma was incorporated in the year 1981 and has been engaged in the manufacture of pharmaceutical products. Located in the Thane district of Maharashtra, the manufacturing unit has capacity to produce capsules, tablets and syrups. The registered office is located at E-15, Nisarag Heaven Building, Dahanukar Wadi, Mahavir Nagar, Mumbai 400067.

Business areas of the company:

The company engages in the manufacture of pharmaceutical products.

Read More Read Less